Skip to main content
. 2018 Feb 1;2018(2):CD004879. doi: 10.1002/14651858.CD004879.pub5

ab Wright 1976a.

Methods 2 studies are reported in the paper:
  • RCT conducted on infants to determine safety and reactogenicity of monovalent flu inactivated vaccine (Wright 1976 2)

  • Placebo‐controlled cohort study carried out on preschool children (Wright 1976 1)

Participants 33 preschool children aged 3 to 6 were enrolled in Wright 1976 1.
 35 children enrolled in the Pediatric Vaccine Clinic at Vanderbilt Hospital (Nashville, Tennessee) aged between 12 and 28 months
Interventions Children randomly received a single dose of 0.25 mL of monovalent inactivated flu vaccine B/Hong Kong/5/72 (zonally purified, Eli Lilly and Company) containing at least 250 CCA units per dose or saline control at the time of a routine clinic visit. Wright 1976 1 was conducted on preschool children. All children from 1 classroom received 1 dose of vaccine; 8 children from another classroom consisting of 12 children received vaccine, whereas the remaining 4 were given saline solution in double‐blind manner. 3 of these 4 controls received 1 dose of vaccine 6 weeks later.
Outcomes Serological
 Haemagglutinin inhibition antibody test against 4 units of Flu/B/HK/8/73 antigen
Effectiveness
 N/A
Safety
 Parents of the children completed a questionnaire to record local and systemic reactions such as the temperature at 20:00 on the day of vaccination. Parents were unaware if the children received immunisation.
Funding Source Industry
Notes Parents of the children completed a questionnaire to record local and systemic reactions such as the temperature at 20:00 on the day of vaccination. Parents were unaware if the children received immunisation.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not described
Allocation concealment (selection bias) High risk Not used
Blinding (performance bias and detection bias) 
 All outcomes Unclear risk Single
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No losses to follow‐up
Summary assessments High risk Insufficient information to assess study design